These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Maternal and fetal epoxyeicosatrienoic acids in normotensive and preeclamptic pregnancies. Jiang H; McGiff JC; Fava C; Amen G; Nesta E; Zanconato G; Quilley J; Minuz P Am J Hypertens; 2013 Feb; 26(2):271-8. PubMed ID: 23382413 [TBL] [Abstract][Full Text] [Related]
44. Cytochrome P450 subfamily 2J polypeptide 2 expression and circulating epoxyeicosatrienoic metabolites in preeclampsia. Herse F; Lamarca B; Hubel CA; Kaartokallio T; Lokki AI; Ekholm E; Laivuori H; Gauster M; Huppertz B; Sugulle M; Ryan MJ; Novotny S; Brewer J; Park JK; Kacik M; Hoyer J; Verlohren S; Wallukat G; Rothe M; Luft FC; Muller DN; Schunck WH; Staff AC; Dechend R Circulation; 2012 Dec; 126(25):2990-9. PubMed ID: 23155181 [TBL] [Abstract][Full Text] [Related]
45. Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health. Morisseau C; Hammock BD Annu Rev Pharmacol Toxicol; 2013; 53():37-58. PubMed ID: 23020295 [TBL] [Abstract][Full Text] [Related]
46. A potent soluble epoxide hydrolase inhibitor, t-AUCB, acts through PPARγ to modulate the function of endothelial progenitor cells from patients with acute myocardial infarction. Xu DY; Davis BB; Wang ZH; Zhao SP; Wasti B; Liu ZL; Li N; Morisseau C; Chiamvimonvat N; Hammock BD Int J Cardiol; 2013 Aug; 167(4):1298-304. PubMed ID: 22525341 [TBL] [Abstract][Full Text] [Related]
47. An eicosanoid-centric view of atherothrombotic risk factors. Gleim S; Stitham J; Tang WH; Martin KA; Hwa J Cell Mol Life Sci; 2012 Oct; 69(20):3361-80. PubMed ID: 22491820 [TBL] [Abstract][Full Text] [Related]
48. Inhibition of soluble epoxide hydrolase by cis-4-[4-(3-adamantan-1-ylureido)cyclohexyl-oxy]benzoic acid exhibits antihypertensive and cardioprotective actions in transgenic rats with angiotensin II-dependent hypertension. Neckář J; Kopkan L; Husková Z; Kolář F; Papoušek F; Kramer HJ; Hwang SH; Hammock BD; Imig JD; Malý J; Netuka I; Ošťádal B; Červenka L Clin Sci (Lond); 2012 Jun; 122(11):513-25. PubMed ID: 22324471 [TBL] [Abstract][Full Text] [Related]
50. The red blood cell participates in regulation of the circulation by producing and releasing epoxyeicosatrienoic acids. Jiang H; Anderson GD; McGiff JC Prostaglandins Other Lipid Mediat; 2012 Aug; 98(3-4):91-3. PubMed ID: 22178722 [TBL] [Abstract][Full Text] [Related]
51. Current and emerging strategies for the treatment and management of systemic lupus erythematosus based on molecular signatures of acute and chronic inflammation. Das UN J Inflamm Res; 2010; 3():143-70. PubMed ID: 22096364 [TBL] [Abstract][Full Text] [Related]
52. A defect in the activities of Δ and Δ desaturases and pro-resolution bioactive lipids in the pathobiology of non-alcoholic fatty liver disease. Das UN World J Diabetes; 2011 Nov; 2(11):176-88. PubMed ID: 22087354 [TBL] [Abstract][Full Text] [Related]
53. Coronary artery ligation and intramyocardial injection in a murine model of infarction. Virag JA; Lust RM J Vis Exp; 2011 Jun; (52):. PubMed ID: 21673649 [TBL] [Abstract][Full Text] [Related]
54. Influence of silencing soluble epoxide hydrolase with RNA interference on cardiomyocytes apoptosis induced by doxorubicin. Du G; Lv J; He L; Ma Y J Huazhong Univ Sci Technolog Med Sci; 2011 Jun; 31(3):324. PubMed ID: 21671172 [TBL] [Abstract][Full Text] [Related]
55. Lipoxins as biomarkers of lupus and other inflammatory conditions. Das UN Lipids Health Dis; 2011 May; 10():76. PubMed ID: 21569625 [TBL] [Abstract][Full Text] [Related]
56. Myocardial pharmacokinetics of ebastine, a substrate for cytochrome P450 2J, in rat isolated heart. Kang W; Elitzer S; Noh K; Bednarek T; Weiss M Br J Pharmacol; 2011 Aug; 163(8):1733-9. PubMed ID: 21410688 [TBL] [Abstract][Full Text] [Related]